Martinelli, Erika

Synergistic antitumor activity of sorafenib in combination with epidermal growth factor receptor inhibitors in colorectal and lung cancer cells. [electronic resource] - Clinical cancer research : an official journal of the American Association for Cancer Research Oct 2010 - 4990-5001 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

1557-3265

10.1158/1078-0432.CCR-10-0923 doi


Animals
Antibodies, Monoclonal--administration & dosage
Antibodies, Monoclonal, Humanized
Antineoplastic Combined Chemotherapy Protocols--pharmacology
Benzenesulfonates--administration & dosage
Carcinoma, Non-Small-Cell Lung--drug therapy
Cell Growth Processes--drug effects
Cell Line, Tumor
Cell Movement--drug effects
Cetuximab
Colorectal Neoplasms--drug therapy
Drug Synergism
ErbB Receptors--antagonists & inhibitors
Erlotinib Hydrochloride
Female
HCT116 Cells
HT29 Cells
Humans
Lung Neoplasms--drug therapy
Mice
Mice, Nude
Niacinamide--analogs & derivatives
Phenylurea Compounds
Protein Kinase Inhibitors--administration & dosage
Pyridines--administration & dosage
Quinazolines--administration & dosage
Receptors, Vascular Endothelial Growth Factor--biosynthesis
Signal Transduction--drug effects
Sorafenib
Xenograft Model Antitumor Assays